Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Entrada Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
38
−9 vs. Q1 2022
Shares held
24.8M
−1.10M (−4.2%) vs. Q1 2022
Total value
$301.8M
+$59.0M (+24.3%) vs. Q1 2022
New holders
8
5 more added
Sold out
17
15 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 38 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 46 institutionsQ1 2022: 48 institutionsQ2 2022: 38 institutionsQ3 2022: 33 institutionsQ4 2022: 47 institutionsQ1 2023: 53 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 62 institutionsQ1 2024: 77 institutionsQ2 2024: 84 institutionsQ3 2024: 97 institutionsQ4 2024: 102 institutionsQ1 2025: 110 institutionsQ2 2025: 107 institutionsQ3 2025: 116 institutionsQ4 2025: 113 institutionsQ1 2026: 119 institutionsQ2 2026: 128 institutions
Value heldQ2 2022: $301.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $433.8MQ1 2022: $242.8MQ2 2022: $301.8MQ3 2022: $386.4MQ4 2022: $334.2MQ1 2023: $361.0MQ2 2023: $389.9MQ3 2023: $411.4MQ4 2023: $396.6MQ1 2024: $368.8MQ2 2024: $423.1MQ3 2024: $481.1MQ4 2024: $529.8MQ1 2025: $274.5MQ2 2025: $198.8MQ3 2025: $164.8MQ4 2025: $251.0MQ1 2026: $321.4MQ2 2026: $214.4M
Institutions holding TRDA and their total value by quarter
QuarterHoldersValue
Q2 2026128$214.4M
Q1 2026119$321.4M
Q4 2025113$251.0M
Q3 2025116$164.8M
Q2 2025107$198.8M
Q1 2025110$274.5M
Q4 2024102$529.8M
Q3 202497$481.1M
Q2 202484$423.1M
Q1 202477$368.8M
Q4 202362$396.6M
Q3 202355$411.4M
Q2 202356$389.9M
Q1 202353$361.0M
Q4 202247$334.2M
Q3 202233$386.4M
Q2 202238$301.8M
Q1 202248$242.8M
Q4 202146$433.8M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding TRDA in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP4,865,819$59.3M0.34%+161,400+3.4%Added
MPM Asset Management LLC4,425,784$53.9M22.75%00.0%Unchanged
5AM Venture Management, LLC4,408,379$53.7M13.28%00.0%Unchanged
Price T Rowe Associates Inc2,437,498$29.7M0.00%−57,216−2.3%Reduced
Redmile Group, LLC1,954,419$23.8M0.91%00.0%Unchanged
Wellington Management Group LLP1,535,883$18.7M0.00%−1,007,219−39.6%Reduced
FMR LLC944,908$11.5M0.00%+68,114+7.8%Added
Vanguard Group Inc762,364$9.29M0.00%+331,960+77.1%Added
TCG Crossover Management, LLC663,694$8.08M3.43%00.0%Unchanged
StepStone Group LP634,959$7.73M0.83%−126,318−16.6%Reduced
72 Investment Holdings, LLC509,023$6.20M9.58%00.0%Unchanged
Goldman Sachs Group Inc445,686$5.43M0.00%+231+0.1%Added
Nan Fung Group Holdings Ltd173,582$2.11M1.45%00.0%Unchanged
CHI Advisors LLC163,496$1.99M0.76%+163,496New
Laurion Capital Management LP129,066$1.57M0.07%+129,066New
Suvretta Capital Management, LLC106,000$1.29M0.05%00.0%Unchanged
Moore Capital Management, LP105,000$1.28M0.04%00.0%Unchanged
Geode Capital Management, LLC101,771$1.24M0.00%−75,962−42.7%Reduced
Millennium Management LLC76,498$932.0K0.00%+76,498New
BlackRock Inc.64,999$791.0K0.00%−380,521−85.4%Reduced
TD Asset Management Inc57,675$702.0K0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The41,175$532.4K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc42,782$522.0K0.00%−25,922−37.7%Reduced
State Street Corp30,194$368.0K0.00%−121,000−80.0%Reduced
Morgan Stanley21,185$258.0K0.00%+12,824+153.4%Added
Ergoteles LLC18,807$229.0K0.01%+18,807New
Northern Trust Corp16,328$199.0K0.00%−73,930−81.9%Reduced
Citadel Advisors LLC12,947$158.0K0.00%−51,452−79.9%Reduced
Bank of America Corp12,991$158.0K0.00%−7,880−37.8%Reduced
Old Well Partners, LLC12,700$155.0K0.12%+12,700New
Cubist Systematic Strategies, LLC1,874$23.0K0.00%+1,874New
UBS Group AG597$8.00K0.00%−850−58.7%Reduced
Advisor Group Holdings, Inc.300$4.00K0.00%+300New
Wells Fargo & Company113$2.00K0.00%−2,172−95.1%Reduced
New York State Common Retirement Fund109$1.00K0.00%−4,771−97.8%Reduced
Citigroup Inc94$1.00K0.00%−319−77.2%Reduced
Barclays PLC36$00.00%−1,673−97.9%Reduced
Credit Suisse AG6$00.00%+6New
Walleye Capital LLC0$00.00%−44,652−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−21,933−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−15,000−100.0%Sold out
Nuveen Asset Management, LLC0$00.00%−13,872−100.0%Sold out
Renaissance Technologies LLC0$00.00%−11,800−100.0%Sold out
American International Group, Inc.0$00.00%−5,223−100.0%Sold out
Deutsche Bank AG0$00.00%−4,959−100.0%Sold out
JPMorgan Chase & Co0$00.00%−4,934−100.0%Sold out
California State Teachers Retirement System0$00.00%−4,446−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−2,485−100.0%Sold out
STRS Ohio0$00.00%−2,100−100.0%Sold out
Amalgamated Bank0$00.00%−1,350−100.0%Sold out
State of Wyoming0$00.00%−1,060−100.0%Sold out
Legal & General Group Plc0$00.00%−848−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−700−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−708−100.0%Sold out
Royal Bank of Canada0$00.00%−646−100.0%Sold out
Amalgamated Financial Corp.––––Not filed